Physician profile
Peter D Candelora
NPI 1376547729
$3,559.59
in general payments reported to CMS, 2019-2025
8 companies · $778 in 2025
The $778 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,179 · 2020: $97.29 · 2021: $663 · 2022: $140 · 2023: $52.44 · 2024: $650 · 2025: $778.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $809 · Travel and Lodging: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.90 |
| Travel and Lodging | $671.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,818.47 | 2019-2025 | Comprehensive Shoulder System, Rosa, Mymobility Platform |
| Arthrex, INC. | $759.55 | 2024-2025 | |
| Coastal Medical Technologies LLC | $526.62 | 2024-2025 | |
| Omnilife Science, INC | $273.92 | 2019 | |
| Mvp Orthopedics INC | $83.74 | 2021 | |
| Encore Medical, Lp | $78.96 | 2020 | |
| Organogenesis INC. | $18.33 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Candelora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.